Qiang Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Qiang Xiao has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Yubo Xie
Department of Anesthesiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China
6 shared publications Lei Li
5 shared publicationsChang-Qing Wang
2 shared publicationsQian Qian
2 shared publicationsXiao
2 shared publicationsXiao-Tong Wang
Department of Surgery, The First Affiliated Hospital Guangxi Medical University Nanning 530021, China
2 shared publications
Latest Publications
- 1 December 2013
- Vol. 33 (12) , 1727-32
[Effects of E2F-1 gene silencing on cisplatin chemosensitivity of human gastric cancer SGC-7901/DDP cells].
To investigate the effects of E2F-1 gene silencing on the chemosensitivity of human gastric cancer SGC-7901/DDP cells to cisplatin and explore the underlying mechanism. Gastric cancer SGC-7901/DDP cells were transfected with the recombinant lentivirirus vector Lv-shRNA-E2F-1 for E2F-1 gene silencing, with cells transfected with the control recombinant lentivirirus vector Lv-shRNA-NC as the negative control. MTT assay was used to evaluate cisplatin chemosensitivity of the cells, and the cell apoptosis rate and cell cycle distribution were detected by flow cytometry. The mRNA and protein expressions of E2F-1 and apoptosis-related genes (survivin and Bcl-2) were detected by RT-PCR and Western blotting. MTT assay showed that the IC50 of cisplatin was significantly lowered in Lv-shRNA-E2F-1-transfected cells compared with the negative and blank control cells (P0.05). E2F-1 gene silencing can enhance cisplatin chemosensitivity of gastric cancer SGC-7901/DDP cells possibly by down-regulating survivin and Bcl-2 expressions, suggesting the value of E2F-1 as a new chemotherapeutic target for gastric cancer.
- 1 December 2013
- Vol. 33 (12) , 1727-32
[Effects of E2F-1 gene silencing on cisplatin chemosensitivity of human gastric cancer SGC-7901/DDP cells].
To investigate the effects of E2F-1 gene silencing on the chemosensitivity of human gastric cancer SGC-7901/DDP cells to cisplatin and explore the underlying mechanism. Gastric cancer SGC-7901/DDP cells were transfected with the recombinant lentivirirus vector Lv-shRNA-E2F-1 for E2F-1 gene silencing, with cells transfected with the control recombinant lentivirirus vector Lv-shRNA-NC as the negative control. MTT assay was used to evaluate cisplatin chemosensitivity of the cells, and the cell apoptosis rate and cell cycle distribution were detected by flow cytometry. The mRNA and protein expressions of E2F-1 and apoptosis-related genes (survivin and Bcl-2) were detected by RT-PCR and Western blotting. MTT assay showed that the IC50 of cisplatin was significantly lowered in Lv-shRNA-E2F-1-transfected cells compared with the negative and blank control cells (P0.05). E2F-1 gene silencing can enhance cisplatin chemosensitivity of gastric cancer SGC-7901/DDP cells possibly by down-regulating survivin and Bcl-2 expressions, suggesting the value of E2F-1 as a new chemotherapeutic target for gastric cancer.
- Open Access
- 26 November 2012
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 31 (1) , 98
Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures
Cdx2 is a homeobox domain-containing transcription factor that is important in the development and differentiation of the intestinal cells, and served as a potential biomarker of tumor progression in early intestinal-type gastric cancer. However, its prognostic value and significance in gastric cancer remain controversial. A meta-analysis based on published studies was performed to obtain an accurate evaluation of the association between the presence of Cdx2-positive in clinical samples and clinical outcome. A total of 13 eligible retrospective cohort studies with 1513 patients were included. Cdx2-positive cases were significantly associated with higher male-to-female ratio (RR=1.27, 95% CI: 1.17–1.38, PPP=0.002 fixed-effect) and lymph node metastasis (RR=1.52, 95% CI: 1.33-1.73, PP<0.00001 fixed-effect). However, the presence of Cdx2 was not associated with tumor size. In summary, Cdx2 is a prognostic factor in gastric cancer, which acts as a marker of good outcome in patients with gastric cancer. Further clinical studies are needed to confirm the role of Cdx2 in clinical practice.
- 26 November 2012
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 31 (1) , 98
Open AccessPrognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures
Cdx2 is a homeobox domain-containing transcription factor that is important in the development and differentiation of the intestinal cells, and served as a potential biomarker of tumor progression in early intestinal-type gastric cancer. However, its prognostic value and significance in gastric cancer remain controversial. A meta-analysis based on published studies was performed to obtain an accurate evaluation of the association between the presence of Cdx2-positive in clinical samples and clinical outcome. A total of 13 eligible retrospective cohort studies with 1513 patients were included. Cdx2-positive cases were significantly associated with higher male-to-female ratio (RR=1.27, 95% CI: 1.17–1.38, PPP=0.002 fixed-effect) and lymph node metastasis (RR=1.52, 95% CI: 1.33-1.73, PP<0.00001 fixed-effect). However, the presence of Cdx2 was not associated with tumor size. In summary, Cdx2 is a prognostic factor in gastric cancer, which acts as a marker of good outcome in patients with gastric cancer. Further clinical studies are needed to confirm the role of Cdx2 in clinical practice.
- Open Access
- 1 January 2011
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 43 (11) , 638-645
Lentivirus-mediated RNA interference targeting E2F-1 inhibits human gastric cancer MGC-803 cell growthin vivo
Experimental & Molecular Medicine is an open access journal that publishes the highest quality articles in translational research and biomedical studies.
- 1 January 2011
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 43 (11) , 638-645
Open AccessLentivirus-mediated RNA interference targeting E2F-1 inhibits human gastric cancer MGC-803 cell growthin vivo
Experimental & Molecular Medicine is an open access journal that publishes the highest quality articles in translational research and biomedical studies.
- Open Access
- 1 January 2010
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 18 (3) , 245-249
Construction and identification of a lentiviral vector for RNA interference of the Cdx2 gene
目的: 构建尾型同源盒基因Cdx2 RNA干扰(RNAi)慢病毒表达载体并进行鉴定. 方法: 选取Cdx2基因的19 nt特异性序列, 设计针对Cdx2的shRNA序列, 应用基因重组技术插入到pLentiLox3.7(pLL3.7)慢病毒表达载体中, Xba I和 Not I进行双酶切和DNA测序鉴定重组克隆, 重组病毒质粒及其3种辅助包装原件载体质粒通过LipofectamineTM2000共转染293T细胞, 培养48 h后, 收集细胞培养上清液, 将其浓缩后在293T细胞中测定病毒滴度. 结果: 通过对pLL-Cdx2-shRNA载体进行双酶切鉴定, 证实短发夹RNA正确插入慢病毒载体, DNA测序证实插入的序列正确, Cdx2基因RNA干扰重组慢病毒载体经293T细胞包装成功, 收集293T细胞分泌的病毒上清测定病毒的滴度为5×107 TU/mL. 结论: 成功构建人Cdx2基因RNAi慢病毒载体, 为研究Cdx2对胃癌生长的影响提供了稳定感染细胞载体.
- 1 January 2010
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 18 (3) , 245-249
Open AccessConstruction and identification of a lentiviral vector for RNA interference of the Cdx2 gene
目的: 构建尾型同源盒基因Cdx2 RNA干扰(RNAi)慢病毒表达载体并进行鉴定. 方法: 选取Cdx2基因的19 nt特异性序列, 设计针对Cdx2的shRNA序列, 应用基因重组技术插入到pLentiLox3.7(pLL3.7)慢病毒表达载体中, Xba I和 Not I进行双酶切和DNA测序鉴定重组克隆, 重组病毒质粒及其3种辅助包装原件载体质粒通过LipofectamineTM2000共转染293T细胞, 培养48 h后, 收集细胞培养上清液, 将其浓缩后在293T细胞中测定病毒滴度. 结果: 通过对pLL-Cdx2-shRNA载体进行双酶切鉴定, 证实短发夹RNA正确插入慢病毒载体, DNA测序证实插入的序列正确, Cdx2基因RNA干扰重组慢病毒载体经293T细胞包装成功, 收集293T细胞分泌的病毒上清测定病毒的滴度为5×107 TU/mL. 结论: 成功构建人Cdx2基因RNAi慢病毒载体, 为研究Cdx2对胃癌生长的影响提供了稳定感染细胞载体.
- 26 December 2009
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 36 (2) , 509-516
Overexpression of Cdx2 inhibits progression of gastric cancer in vitro
The caudal-type homeobox gene Cdx2 encodes a transcription factor which in adult mammals is expressed in the cells of the intestinal epithelium and is thought to play an important role in their proliferation and differentiation. Cdx2 mediates apoptosis and suppresses tumorigenesis in many tissue types, but there are few data available on Cdx2 expression and its relationship to tumor kinetics in gastric cancer. To gain better insight into the involvement of Cdx2 in the biological characteristics of gastric cancer, we investigated the effect of Cdx2 overexpression on the progression of gastric carcinoma cells. A gastric cancer cell line stably overexpressing Cdx2 (MGC-803/Cdx2) was established. The influence of Cdx2 overexpression on in vitro cell growth was assessed by measuring cell survival, colony formation and cell cycle progression. The results clearly showed that overexpression of Cdx2 significantly inhibited cell growth and proliferation, blocking entry into the S phase of the cell cycle. MGC-803/Cdx2 cells also had a higher apoptotic rate than control cells. In addition, Cdx2 reduced the motility and invasion of gastric cancer cells. In summary, Cdx2 overexpression can effectively inhibit gastric cancer progression and may be used as a potent therapy.
- 26 December 2009
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 36 (2) , 509-516
Overexpression of Cdx2 inhibits progression of gastric cancer in vitro
The caudal-type homeobox gene Cdx2 encodes a transcription factor which in adult mammals is expressed in the cells of the intestinal epithelium and is thought to play an important role in their proliferation and differentiation. Cdx2 mediates apoptosis and suppresses tumorigenesis in many tissue types, but there are few data available on Cdx2 expression and its relationship to tumor kinetics in gastric cancer. To gain better insight into the involvement of Cdx2 in the biological characteristics of gastric cancer, we investigated the effect of Cdx2 overexpression on the progression of gastric carcinoma cells. A gastric cancer cell line stably overexpressing Cdx2 (MGC-803/Cdx2) was established. The influence of Cdx2 overexpression on in vitro cell growth was assessed by measuring cell survival, colony formation and cell cycle progression. The results clearly showed that overexpression of Cdx2 significantly inhibited cell growth and proliferation, blocking entry into the S phase of the cell cycle. MGC-803/Cdx2 cells also had a higher apoptotic rate than control cells. In addition, Cdx2 reduced the motility and invasion of gastric cancer cells. In summary, Cdx2 overexpression can effectively inhibit gastric cancer progression and may be used as a potent therapy.
- 5 November 2009
- Published by Editorial Office of Chinese Journal of Cancer in Chinese Journal of Cancer
- Vol. 28 (11) , 1176-1180
Effects of E2F-1 overexpression on apoptosis of gastric cancer cells and expressions of apoptosis-related genes
E2F transcription factor 1 (E2F-1) is an important transcription factor in cell cycle. This study was to investigate the effects of E2F-1 overexpression on apoptosis of gastric cancer MGC-803 cells and expressions of the downstream genes. The apoptotic rates were measured by flow cytometry in MGC-803/E2F-1 cells, MGC-803/EV cells or untransfected MGC-803 cells. The total RNA was extracted from MGC-803/E2F-1 cells or MGC-803 cells, and cDNA was obtained by RT-PCR. Fluorescent (fluorescence exchange clip) probes marked by Cy5 and Cy3 were hybridized with gene chips containing 21522 human genes. Subsequently, the two signal images were scanned by Lux Scan 10K/A dual pathways laser scanner and analyzed by LuxScan3.0 image analysis software. RT-PCR was used to verify the target genes. The apoptotic rate of MGC-803/E2F-1 cells [(8.40+/-0.91)%] was higher than that of MGC-803/EV [(4.53+/-0.61)%] and MGC-803 cells [(4.97+/-0.47)%]. Fifteen differentially expressed apoptosis-related genes were detected, 4 of which were up-expressed and 11 were down-expressed genes, and the same results were verified by RT-PCR. Overexpression of E2F-1 accelerates apoptosis of gastric carcinoma MGC-803 cells, which may be related to the 15 differentially expressed genes.
- 5 November 2009
- Published by Editorial Office of Chinese Journal of Cancer in Chinese Journal of Cancer
- Vol. 28 (11) , 1176-1180
Effects of E2F-1 overexpression on apoptosis of gastric cancer cells and expressions of apoptosis-related genes
E2F transcription factor 1 (E2F-1) is an important transcription factor in cell cycle. This study was to investigate the effects of E2F-1 overexpression on apoptosis of gastric cancer MGC-803 cells and expressions of the downstream genes. The apoptotic rates were measured by flow cytometry in MGC-803/E2F-1 cells, MGC-803/EV cells or untransfected MGC-803 cells. The total RNA was extracted from MGC-803/E2F-1 cells or MGC-803 cells, and cDNA was obtained by RT-PCR. Fluorescent (fluorescence exchange clip) probes marked by Cy5 and Cy3 were hybridized with gene chips containing 21522 human genes. Subsequently, the two signal images were scanned by Lux Scan 10K/A dual pathways laser scanner and analyzed by LuxScan3.0 image analysis software. RT-PCR was used to verify the target genes. The apoptotic rate of MGC-803/E2F-1 cells [(8.40+/-0.91)%] was higher than that of MGC-803/EV [(4.53+/-0.61)%] and MGC-803 cells [(4.97+/-0.47)%]. Fifteen differentially expressed apoptosis-related genes were detected, 4 of which were up-expressed and 11 were down-expressed genes, and the same results were verified by RT-PCR. Overexpression of E2F-1 accelerates apoptosis of gastric carcinoma MGC-803 cells, which may be related to the 15 differentially expressed genes.
- 1 June 2009
- Published by Wiley in Cell Biology International
- Vol. 33 (6) , 640-649
Overexpression of E2F-1 inhibits progression of gastric cancer in vitro
E2F-1 plays a critical role in cell cycle regulation and other biological processes in cells. E2F-1 mediates apoptosis and suppresses tumorigenesis in many tissue types, but there are few data available on E2F-1 expression and its relationship to tumor kinetics in gastric cancer. To gain better insight into the involvement of E2F-1 in the biological characteristics of gastric tumors, we investigated the effect of E2F-1 overexpression on the progression of gastric carcinoma cells. A gastric cancer cell line stably overexpressing E2F-1 (MGC-803/E2F-1) was established. The influence of E2F-1 overexpression on in vitro cell growth was assessed by measuring cell survival, colony formation, and cell cycle progression. The results clearly show that overexpression of E2F-1 significantly inhibits cell growth and proliferation, blocking entry into the S-phase of the cell cycle. MGC-803/E2F-1 cells also had a higher apoptotic rate than control cells. In addition, E2F-1 reduced the motility and invasion of gastric cancer cells.
- 1 June 2009
- Published by Wiley in Cell Biology International
- Vol. 33 (6) , 640-649
Overexpression of E2F-1 inhibits progression of gastric cancer in vitro
E2F-1 plays a critical role in cell cycle regulation and other biological processes in cells. E2F-1 mediates apoptosis and suppresses tumorigenesis in many tissue types, but there are few data available on E2F-1 expression and its relationship to tumor kinetics in gastric cancer. To gain better insight into the involvement of E2F-1 in the biological characteristics of gastric tumors, we investigated the effect of E2F-1 overexpression on the progression of gastric carcinoma cells. A gastric cancer cell line stably overexpressing E2F-1 (MGC-803/E2F-1) was established. The influence of E2F-1 overexpression on in vitro cell growth was assessed by measuring cell survival, colony formation, and cell cycle progression. The results clearly show that overexpression of E2F-1 significantly inhibits cell growth and proliferation, blocking entry into the S-phase of the cell cycle. MGC-803/E2F-1 cells also had a higher apoptotic rate than control cells. In addition, E2F-1 reduced the motility and invasion of gastric cancer cells.
- Open Access
- 6 April 2009
- Published by Spandidos Publications in Oncology Reports
- Vol. 21 (5) , 1345-1353
Short interfering RNA directed against the E2F-1 gene suppressing gastric cancer progression in vitro
Gastric cancer is the third most common cancer in China. The sustained overexpression of E2F-1 is a characteristic feature of gastric cancer. RNA interference (RNAi), which has been proven to be a powerful tool for suppressing gene expression, may provide a promising way forward in gastric cancer therapy. In this study, we constructed the recombinant Psilencer 4.1- E2F-1 siRNA plasmids and transfected them into gastric cancer MGC-803 cells in vitro. Our data demonstrated that E2F-1 siRNA led to inhibition of endogenous E2F-1 mRNA and protein expression as determined by real-time quantitative RT-PCR and Western blotting. Furthermore, simultaneous silencing of E2F-1 resulted in a reduction of tumor cell proliferation activity and a higher percentage of apoptotic cells. The inhibition of migration and invasion potential of tumor cells was investigated in vitro. In summary, siRNA targeting of E2F-1 can effectively inhibit gastric cancer progression and may be used as a potent therapy.
- 6 April 2009
- Published by Spandidos Publications in Oncology Reports
- Vol. 21 (5) , 1345-1353
Open AccessShort interfering RNA directed against the E2F-1 gene suppressing gastric cancer progression in vitro
Gastric cancer is the third most common cancer in China. The sustained overexpression of E2F-1 is a characteristic feature of gastric cancer. RNA interference (RNAi), which has been proven to be a powerful tool for suppressing gene expression, may provide a promising way forward in gastric cancer therapy. In this study, we constructed the recombinant Psilencer 4.1- E2F-1 siRNA plasmids and transfected them into gastric cancer MGC-803 cells in vitro. Our data demonstrated that E2F-1 siRNA led to inhibition of endogenous E2F-1 mRNA and protein expression as determined by real-time quantitative RT-PCR and Western blotting. Furthermore, simultaneous silencing of E2F-1 resulted in a reduction of tumor cell proliferation activity and a higher percentage of apoptotic cells. The inhibition of migration and invasion potential of tumor cells was investigated in vitro. In summary, siRNA targeting of E2F-1 can effectively inhibit gastric cancer progression and may be used as a potent therapy.
- Open Access
- 1 January 2009
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 17 (11) , 1069
Effects of E2F-1 gene overexpression on gastric cancer cell dynamics
- 1 January 2009
- Published by Baishideng Publishing Group Inc. in World Chinese Journal of Digestology
- Vol. 17 (11) , 1069
Open AccessEffects of E2F-1 gene overexpression on gastric cancer cell dynamics
- 1 June 2008
- Vol. 46 (11) , 847-50
[Caudal-related homeobox 2 gene expression and its effects on human gastric carcinoma cell line].
To investigate the effect of human caudal-related homeobox 2 (Cdx2) gene expression on human gastric carcinoma cell line MGC-803. pCMV-Cdx2-HA eukaryotic expression plasmid was constructed by using DNA recombinant method. The MGC-803 cells were divided into 4 groups: non-transfected, transfected with pCMV-HA, transfected with pCMV-GAPDH-HA, transfected with pCMV-Cdx2-HA. Cdx2 gene and its protein expression was detected by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot techniques respectively. The effects of Cdx2 overexpression on the growth of MGC-803 cells in vitro was assessed by measuring MTT, flow cytometry and transmission electron microscopy analysis. In MGC-803 cells transfected with pCMV-Cdx2-HA, cell proliferation was significantly suppressed, the cells was ultrastructurally destroyed, cell cycle progression was blocked in G0/G1 and apoptosis rate was higher (P<0.05) in comparison with non-transfected cells or cells transfected with empty vector. It indicated that Cdx2 gene can suppress the growth of gastric carcinoma and may save as a novel therapeutic target.
- 1 June 2008
- Vol. 46 (11) , 847-50
[Caudal-related homeobox 2 gene expression and its effects on human gastric carcinoma cell line].
To investigate the effect of human caudal-related homeobox 2 (Cdx2) gene expression on human gastric carcinoma cell line MGC-803. pCMV-Cdx2-HA eukaryotic expression plasmid was constructed by using DNA recombinant method. The MGC-803 cells were divided into 4 groups: non-transfected, transfected with pCMV-HA, transfected with pCMV-GAPDH-HA, transfected with pCMV-Cdx2-HA. Cdx2 gene and its protein expression was detected by quantitative real-time polymerase chain reaction (qRT-PCR) and Western blot techniques respectively. The effects of Cdx2 overexpression on the growth of MGC-803 cells in vitro was assessed by measuring MTT, flow cytometry and transmission electron microscopy analysis. In MGC-803 cells transfected with pCMV-Cdx2-HA, cell proliferation was significantly suppressed, the cells was ultrastructurally destroyed, cell cycle progression was blocked in G0/G1 and apoptosis rate was higher (P<0.05) in comparison with non-transfected cells or cells transfected with empty vector. It indicated that Cdx2 gene can suppress the growth of gastric carcinoma and may save as a novel therapeutic target.